Evidence map›Paper›PMID 39618486›Full record

ArticleChemistry of materials : a publication of the American Chemical Society2024

Unveiling the Potential of Redox Chemistry to Form Size-Tunable, High-Index Silicon Particles.

Megan A Parker, Safa Khaddad, Nicolas Fares, Anissa Ghoridi, David Portehault, Sébastien Bonhommeau, Yacine Amarouchene, Patrick Rosa, Mathieu Gonidec, Glenna L Drisko

Abstract read
In one paragraph

Article in Chemistry of materials : a publication of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bimetallic Bismuth-Based Nanoparticles From Pseudo-Tetrahedral Zintl Anions.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Megan A ParkerUniversity of Bordeaux, CNRS, Bordeaux-INP, ICMCB, UMR 5026, F-33600 Pessac, France.ORCID https://orcid.org/0009-0000-8377-149X
Safa KhaddadUniversity of Bordeaux, CNRS, Bordeaux-INP, ICMCB, UMR 5026, F-33600 Pessac, France.
Nicolas FaresUniversity of Bordeaux, CNRS, LOMA, UMR 5798, F-33405 Talence, France.
Anissa GhoridiLaboratoire de Chimie de la Matière Condensée de Paris (LCMCP), Sorbonne Université CNRS, F-75005 Paris, France.
David PortehaultLaboratoire de Chimie de la Matière Condensée de Paris (LCMCP), Sorbonne Université CNRS, F-75005 Paris, France.ORCID https://orcid.org/0000-0003-4914-4913
Sébastien BonhommeauUniversity of Bordeaux, CNRS, Bordeaux-INP, ISM, UMR 5255, F-33400 Talence, France.ORCID https://orcid.org/0000-0002-9213-7201
Yacine AmaroucheneUniversity of Bordeaux, CNRS, LOMA, UMR 5798, F-33405 Talence, France.
Patrick RosaUniversity of Bordeaux, CNRS, Bordeaux-INP, ICMCB, UMR 5026, F-33600 Pessac, France.ORCID https://orcid.org/0000-0001-5670-2624
Mathieu GonidecUniversity of Bordeaux, CNRS, Bordeaux-INP, ICMCB, UMR 5026, F-33600 Pessac, France.ORCID https://orcid.org/0000-0002-0187-1305
Glenna L DriskoUniversity of Bordeaux, CNRS, Bordeaux-INP, ICMCB, UMR 5026, F-33600 Pessac, France.ORCID https://orcid.org/0000-0001-6469-9736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silicon particles of intermediate sizes (75-200 nm) scatter visible wavelengths, making them promising candidates for optical devices. The solution synthesis of silicon particles in this size range, however, has proved challenging for chemists over the past few decades. Here, a solution-phase synthesis provides a pathway toward reaching size tunability between 45 and 230 nm via changing the reactant ratio in the reaction between a silicon Zintl phase (Na

Identifiers

PMID39618486
PMCPMC11603531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.